Prof. Anthony Moorman presenting at the CCLG Annual Conference in Manchester, discussing how the VIVO Biobank and research from the Leukaemia Research Cytogenetics Group support advances in acute leukaemia research.

Prof. Anthony Moorman presenting at the CCLG Annual Conference in Manchester, discussing how the VIVO Biobank and research from the Leukaemia Research Cytogenetics Group support advances in acute leukaemia research.

Prof. Anthony Moorman presenting at the CCLG Annual Conference in Manchester, discussing how the VIVO Biobank and research from the Leukaemia Research Cytogenetics Group support advances in acute leukaemia research.

Great to be at the Annual Conference of @cclguk.bsky.social in Manchester.

Prof. @avmoorman.bsky.social shared how the VIVO Biobank supports acute leukaemia research, highlighting key research from @lrcg.bsky.social, including the UKALL CNA profile in the ALLTogether trial.🧬🤝

The talk focused on risk stratification in 𝑩-𝒄𝒆𝒍𝒍 𝑨𝒄𝒖𝒕𝒆 𝑳𝒚𝒎𝒑𝒉𝒐𝒃𝒍𝒂𝒔𝒕𝒊𝒄 𝑳𝒆𝒖𝒌𝒂𝒆𝒎𝒊𝒂 (𝑩-𝑨𝑳𝑳), emphasizing the role of cytogenetic approaches in identifying patient risk profiles and guiding treatment strategies🔬📊.

The talk focused on risk stratification in 𝑩-𝒄𝒆𝒍𝒍 𝑨𝒄𝒖𝒕𝒆 𝑳𝒚𝒎𝒑𝒉𝒐𝒃𝒍𝒂𝒔𝒕𝒊𝒄 𝑳𝒆𝒖𝒌𝒂𝒆𝒎𝒊𝒂 (𝑩-𝑨𝑳𝑳), emphasizing the role of cytogenetic approaches in identifying patient risk profiles and guiding treatment strategies🔬📊.

𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒊𝒏𝒈 𝑩-𝒄𝒆𝒍𝒍 𝑨𝒄𝒖𝒕𝒆 𝑳𝒚𝒎𝒑𝒉𝒐𝒃𝒍𝒂𝒔𝒕𝒊𝒄 𝑳𝒆𝒖𝒌𝒂𝒆𝒎𝒊𝒂 (𝑩-𝑨𝑳𝑳) 𝒓𝒆𝒔𝒆𝒂𝒓𝒄𝒉🧬

Our group lead @avmoorman.bsky.social presented on risk stratification in B-ALL at the International ALL Assembly, sponsored by @amgen.bsky.social. Great opportunity to share our work with the international research community.

Exciting milestone as we held BIOINFORM project kick-off at @newcastleuni.bsky.social, funded by @crukpolicy.bsky.social. The day began with presentations tracing the history of LRCG and introducing the different work packages that will drive the BIOINFORM project forward.
@avmoorman.bsky.social

Alumnus who survived teenage cancer welcomes multi-million funding A Newcastle University graduate who survived cancer as a teen and was inspired to become a doctor by those who cared for him, is welcoming a multi-million pound investment from Cancer Research UK.

www.ncl.ac.uk/press/articl...

Professor Christine Harrison collecting her OBE for services to childhood cancer research on 22nd July @buckinghampalace.bsky.social

#leukaemia #cancer
@bcuk.bsky.social @nucancer.bsky.social
@newcastleuni.bsky.social @cancerresearchuk.org @cclguk.bsky.social

We are hiring! Great opportunity for a RA with bioinformatic skills

We are looking for talented researcher to work on a project to detect gene fusions and driver mutations in a large cohort of children with ALL treated across multiple different trials to determine their clinical relevance.

Delighted to be present when Christine Harrison was awarded a SIOP-E lifetime achievement award at the 2025 annual meeting in Budapest. A richly deserved recognition of a brilliant career. @nucancer.bsky.social @bcuk.bsky.social @cancerresearchuk.org

Great opportunity to join the Wolfson Childhood Cancer Research Centre at Newcastle University

We looking to recruit a junior research fellow in childhood leukaemia/cancer.

jobs.ncl.ac.uk/job/Newcastl...

#WeAreNcl @nucancer.bsky.social

Delighted to be at the EMBO workshop in Kolkata celebrating the 10th anniversary of the translational institute set up by Vaskar Saha And Shekhar Krishan

Excellent news. Richly deserved honour.

Blood Cancer UK | Blood cancer researcher recognised in King’s New Years Honours The King’s New Years Honours list has been announced with Blood Cancer UK's trustee awarded an OBE for services to children.

Delighted to see that Christine Harrison has been awarded an OBE in the NY Honours List. A wonderful recognition for excellent childhod leukaemia research. Congratulations!

#leukaemia #newcastleuniversity #lrcg #research #cancer #leukemia @nucancer.bsky.social

bloodcancer.org.uk/news/blood-c...

Last few days to submit an abstract for this meeting! #ChildhoodLeukaemia #EMBO

Promotional image for Newcastle University highlighting its ranking in the top 60 of the QS World University Rankings for Sustainability 2025. The photo features a lush campus courtyard with traditional red brick buildings and walking paths.

🎉 We're celebrating being listed one of the world's top 60 universities for sustainability by QS.

We're also joint 3rd in the world for health and wellbeing impact - recognising our mission to help people around the globe live longer and healthier lives.

#WeAreNCL #QSWUR

We are one of just 7 UK cancer centres that are contributing to the CRUK Black Leaders in Cancer PhD Scholarship Programme. We have 10 exciting projects on offer to eligible candidates of Black heritage backgrounds. Read more about the scheme and what we have on offer www.ncl.ac.uk/cancer/train...

Hi everyone 👋

Bluesky is growing so rapidly – so we want to share some key information about cancer, for anyone here who might need it.

Nearly 1 in 2 people in the UK will get cancer – so if this thread might be of use to anyone you know, please pass it on to them.

1/3

Genomic profiling of circulating tumor DNA for childhood cancers - Leukemia Leukemia - Genomic profiling of circulating tumor DNA for childhood cancers

Glad to share the work of the fantastic Cancer Biomarkers Laboratory of St Jude showing the power and utility of cell free genomic analysis to detect diverse genomic variants in leukemia and many solid tumors. Exciting potential for mutation-specific monitoring. www.nature.com/articles/s41...

🌟 Registration is OPEN for the CCLG + TYAC Annual Conference 2025, a must-attend event for #clinical, #healthcare, and #research professionals working in children and young people's cancer.

⏰ Early bird discount for members ends 16 Jan 2025!

View the programme & register bit.ly/3H6gaTu

#CCLG2025

Professor Christina Halsey is leading a new CCLG project into the late effects of #leukaemia treatment!🎗️

Funded by our Special Named Funds: The Riley Cameron Forget Me Not Fund, The Toti Worboys Fund, Fred Bennett’s ‘Don’t Look Down’ Fund & Arabella’s Leukaemia (ALL) Research Fund.

bit.ly/3ZO0Sx1

Molecular Basis and Mechanisms of Therapy Personalisation in Paediatric Leukaemia Only in the last decade have clinicians in India, with support from colleagues from the west, organized to develop multi-centre modern protocols for children with acute leukaemia. These protocols inc…

Registration and abstract submission is now open for this EMBO Childhood Leukaemia workshop that I am excited to help organise. See you in Kolkata!!